Is Evaluation of the Presence of Prepectoral Edema on T2-weighted with Fat-suppression 3 T Breast MRI a Simple and Readily Available Noninvasive Technique for Estimation of Prognosis in Patients with Breast Cancer?
Overview
Affiliations
Background: The specificity of breast MRI is only moderate. The unsatisfactory specificity of breast MRI has prompted evaluation of high signal intensity (SI) on T2-weighted imaging (T2WI). The purpose of the study was to investigate the prevalence of prepectoral edema determined using high SI on T2WI with fat-suppression 3 T MRI and to correlate its presence with prognostic factors of breast cancer.
Methods: The retrospective study comprised 589 consecutive histopathologically confirmed lesions, 460 malignant and 129 benign, identified by 3 T MRI. Presence of prepectoral edema was evaluated on T2WI with fat suppression, and its diagnostic value for malignancies and correlation with clinicopathological findings in histopathologically confirmed breast cancer were assessed.
Results: Prepectoral edema was present in 54 of the 460 breast cancers (9 % of the total 589) and none of the 129 benign lesions. Its sensitivity and specificity were 12 and 100 %, respectively. The positive predictive value was 100 %. Young age (p = 0.01), large tumor size (p < 0.0001), high histological grade (p < 0.0001), invasive ductal carcinoma (p < 0.0001), high lymphovascular invasion degree (p < 0.0001), high axillary lymph node positivity (p < 0.0001), high inflammatory breast cancer rate (p < 0.0001), high neoadjuvant chemotherapy rate (p < 0.0001), and chemoresistant breast cancers (p < 0.0001) were significantly associated with prepectoral edema. There was no association of the morphological lesion type on MRI and dynamic enhancement imaging pattern with the presence of prepectoral edema.
Conclusion: Prepectoral edema has low prevalence but is specific for breast cancer and correlated with prognostic factors.
Hu J, Ke J, Xu S, Pei L, Cao L, Zhou H BMC Med Imaging. 2024; 24(1):332.
PMID: 39639228 PMC: 11622627. DOI: 10.1186/s12880-024-01518-8.
He Y, Duan S, Wang W, Yang H, Pan S, Cheng W NPJ Breast Cancer. 2024; 10(1):72.
PMID: 39112498 PMC: 11306571. DOI: 10.1038/s41523-024-00678-8.
The Role of MRI in Breast Cancer and Breast Conservation Therapy.
Washington I, Palm R, White J, Rosenberg S, Ataya D Cancers (Basel). 2024; 16(11).
PMID: 38893241 PMC: 11171236. DOI: 10.3390/cancers16112122.
Tani N, Koreeda Y, Nawata A, Fujisaki A, Hayashida Y, Shimajiri S Magn Reson Med Sci. 2024; 24(1):112-121.
PMID: 38325834 PMC: 11733510. DOI: 10.2463/mrms.mp.2023-0127.
Sung P, Lee J, Cheun J, Choi I, Park J, Park J J Breast Cancer. 2023; 26(5):479-491.
PMID: 37704381 PMC: 10625867. DOI: 10.4048/jbc.2023.26.e35.